Literature DB >> 15794078

The SF-36 health status questionnaire in assessing patients with epistaxis secondary to hereditary hemorrhagic telangiectasia.

Penelope A Lennox1, Anne E Hitchings, Valerie J Lund, David J Howard.   

Abstract

BACKGROUND: This study assesses the ability of the short form 36 (SF-36), a validated health status survey, to measure the health of patients with epistaxis due to hereditary hemorrhagic telangiectasia (HHT).
METHODS: Thirty-eight patients completed the SF-36 and symptom-specific questionnaires. They were asked to rate their epistaxis as severe, moderate, or mild. The SF-36 data are compared with a reference population and analyzed with respect to the subgroups.
RESULTS: The scores for each dimension of health were significantly reduced (p < 0.05) when compared with the reference population for all dimensions except pain. When compared with the patients' ratings of severity, a significant correlation was detected in five dimensions (p < 0.05).
CONCLUSION: The SF-36 reflects the reduced health status of patients with epistaxis due to HHT. Changes in the SF-36 score could be used as an outcome measure in assessing efficacy of treatment of this condition.

Entities:  

Mesh:

Year:  2005        PMID: 15794078

Source DB:  PubMed          Journal:  Am J Rhinol        ISSN: 1050-6586


  8 in total

1.  Depression and post-traumatic stress disorder in individuals with hereditary hemorrhagic telangiectasia: A cross-sectional survey.

Authors:  Shruti Chaturvedi; Marianne Clancy; Nicole Schaefer; Olalekan Oluwole; Keith R McCrae
Journal:  Thromb Res       Date:  2017-03-09       Impact factor: 3.944

2.  Efficiency of laser treatment in patients with hereditary hemorrhagic telangiectasia.

Authors:  Gita Jørgensen; Bibi Lange; Jens Højberg Wanscher; Anette Drøhse Kjeldsen
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-06-26       Impact factor: 2.503

3.  Life experiences of individuals with hereditary hemorrhagic telangiectasia and disclosing outside the family: a qualitative analysis.

Authors:  Leigh Ann Higa; Jamie McDonald; Deborah O Himes; Erin Rothwell
Journal:  J Community Genet       Date:  2015-09-04

4.  Impact of pulmonary arteriovenous malformations on respiratory-related quality of life in patients with hereditary haemorrhagic telangiectasia.

Authors:  Sandra Blivet; Daniel Cobarzan; Alain Beauchet; Mostafa El Hajjam; Pascal Lacombe; Thierry Chinet
Journal:  PLoS One       Date:  2014-03-06       Impact factor: 3.240

5.  Trauma Can Induce Telangiectases in Hereditary Hemorrhagic Telangiectasia.

Authors:  Urban Geisthoff; Ha-Long Nguyen; Rolf Lefering; Steffen Maune; Kruthika Thangavelu; Freya Droege
Journal:  J Clin Med       Date:  2020-05-17       Impact factor: 4.241

6.  The effects of nasal closure on quality of life in patients with hereditary hemorrhagic telangiectasia.

Authors:  Rhett S Thomson; Nicole L Molin; Kevin J Whitehead; Shaelene Ashby; Leland Johnson; P Daniel Ward; Bryan R McRae; Kevin F Wilson; Jamie McDonald
Journal:  Laryngoscope Investig Otolaryngol       Date:  2018-04-19

7.  Development and performance of a hereditary hemorrhagic telangiectasia-specific quality-of-life instrument.

Authors:  Raj S Kasthuri; Shruti Chaturvedi; Sonia Thomas; Nathan Vandergrift; Carla Bann; Nicole Schaefer; Marianne S Clancy; Reed Pyeritz; Keith R McCrae
Journal:  Blood Adv       Date:  2022-07-26

8.  Nosebleeds in hereditary hemorrhagic telangiectasia: Development of a patient-completed daily eDiary.

Authors:  Marci Clark; Pamela Berry; Susan Martin; Nimanee Harris; Dennis Sprecher; Scott Olitsky; Jeffrey B Hoag
Journal:  Laryngoscope Investig Otolaryngol       Date:  2018-11-14
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.